140 related articles for article (PubMed ID: 8544899)
1. Alzheimer pathology of patients carrying apolipoprotein E epsilon 4 allele.
Heinonen O; Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Sorvari H; Kosunen O; Paljärvi L; Ryynänen M; Riekkinen PJ
Neurobiol Aging; 1995; 16(4):505-13. PubMed ID: 8544899
[TBL] [Abstract][Full Text] [Related]
2. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
[TBL] [Abstract][Full Text] [Related]
3. Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients.
Kosunen O; Talasniemi S; Lehtovirta M; Heinonen O; Helisalmi S; Mannermaa A; Paljärvi L; Ryynänen M; Riekkinen PJ; Soininen H
Stroke; 1995 May; 26(5):743-8. PubMed ID: 7740560
[TBL] [Abstract][Full Text] [Related]
4. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions.
Ohm TG; Scharnagl H; März W; Bohl J
Acta Neuropathol; 1999 Sep; 98(3):273-80. PubMed ID: 10483785
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E polymorphism and Alzheimer's disease.
Poirier J; Davignon J; Bouthillier D; Kogan S; Bertrand P; Gauthier S
Lancet; 1993 Sep; 342(8873):697-9. PubMed ID: 8103819
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E-epsilon 2 and Alzheimer's disease: genotype influences pathologic phenotype.
Lippa CF; Smith TW; Saunders AM; Hulette C; Pulaski-Salo D; Roses AD
Neurology; 1997 Feb; 48(2):515-9. PubMed ID: 9040748
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains.
Pirttilä T; Soininen H; Mehta PD; Heinonen O; Lehtimäki T; Bogdanovic N; Paljärvi L; Kim KS; Kosunen O; Winblad B; Riekkinen P; Wisniewski HM
Neurobiol Aging; 1997; 18(1):121-7. PubMed ID: 8983040
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E allele epsilon 4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease.
Berr C; Hauw JJ; Delaère P; Duyckaerts C; Amouyel P
Neurosci Lett; 1994 Sep; 178(2):221-4. PubMed ID: 7824200
[TBL] [Abstract][Full Text] [Related]
10. Lack of association of a polymorphism in the low-density lipoprotein receptor-related protein gene with Alzheimer disease.
Clatworthy AE; Gomez-Isla T; Rebeck GW; Wallace RB; Hyman BT
Arch Neurol; 1997 Oct; 54(10):1289-92. PubMed ID: 9341576
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
12. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
Lue LF; Kuo YM; Roher AE; Brachova L; Shen Y; Sue L; Beach T; Kurth JH; Rydel RE; Rogers J
Am J Pathol; 1999 Sep; 155(3):853-62. PubMed ID: 10487842
[TBL] [Abstract][Full Text] [Related]
13. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.
Harrington CR; Louwagie J; Rossau R; Vanmechelen E; Perry RH; Perry EK; Xuereb JH; Roth M; Wischik CM
Am J Pathol; 1994 Dec; 145(6):1472-84. PubMed ID: 7992850
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
Strittmatter WJ; Saunders AM; Schmechel D; Pericak-Vance M; Enghild J; Salvesen GS; Roses AD
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1977-81. PubMed ID: 8446617
[TBL] [Abstract][Full Text] [Related]
15. [Apolipoprotein E4 and late-onset Alzheimer's disease].
Tamaoka A
Nihon Rinsho; 1994 Dec; 52(12):3257-65. PubMed ID: 7853720
[TBL] [Abstract][Full Text] [Related]
16. Inconstant apolipoprotein E (ApoE)-like immunoreactivity in amyloid beta protein deposits: relationship with APOE genotype in aging brain and Alzheimer's disease.
Uchihara T; Duyckaerts C; Lazarini F; Mokhtari K; Seilhean D; Amouyel P; Hauw JJ
Acta Neuropathol; 1996 Aug; 92(2):180-5. PubMed ID: 8841664
[TBL] [Abstract][Full Text] [Related]
17. The effect of apolipoprotein E genotype on expression of an autosomal dominant schizophreniform disorder with progressive dementia and neurofibrillary tangles.
Tsuang D; Raskind MA; Leverenz J; Peskind ER; Schellenberg G; Bird TD
Biol Psychiatry; 1997 Jan; 41(2):191-5. PubMed ID: 9018389
[TBL] [Abstract][Full Text] [Related]
18. [Lipoproteins in clinical laboratory medicine].
Kuriyama M
Rinsho Byori; 1998 Dec; 46(12):1219-25. PubMed ID: 9916507
[TBL] [Abstract][Full Text] [Related]
19. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE
Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]